Zydus Lifesciences Acquires Stake in Sterling Biotech: A Leap into Fermented Animal-Free Protein
Zydus Lifesciences Partners with Perfect Day
New Delhi, Zydus Lifesciences on Saturday announced its agreement to acquire a 50% stake in Sterling Biotech from Perfect Day Inc. The deal will make Sterling Biotech a 50:50 joint venture, ensuring equal representation on the Board. Although financial details remain undisclosed, this strategic move signals Zydus' intent to enter the realm of specialized biotech products aimed at health and nutrition.
Focus on Fermented Animal-Free Protein
- Perfect Day's precision-fermented protein finds applications in a diverse array of products.
- Lower environmental impact distinguishes Perfect Day's offerings in the crowded protein market.
- Sterling Biotech is known for manufacturing fermentation-based API products and gelatine.
According to Zydus Lifesciences MD Sharvil Patel, this partnership exemplifies a dedicated effort to position India as a premier global supply chain hub while continuously exploring innovative collaborations. Perfect Day's Interim CEO Narayan TM emphasized that this partnership significantly enhances their capabilities to meet the surging demands of the global market, creating a win-win scenario that combines both companies' strengths.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.